Literature DB >> 21786091

Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI.

Panagiotis Alexopoulos1, Christian Sorg, Annette Förschler, Timo Grimmer, Maria Skokou, Afra Wohlschläger, Robert Perneczky, Claus Zimmer, Alexander Kurz, Christine Preibisch.   

Abstract

Alzheimer's disease (AD) and mild cognitive impairment (MCI), the transitional clinical stage between cognition in normal aging and dementia, have been linked to abnormalities in brain perfusion. Pulsed arterial spin labeling (PASL) is a magnetic resonance imaging (MRI) technique for evaluating brain perfusion. The present study aimed to determine regional perfusion abnormalities in 19 patients with mild dementia in AD and 24 patients with MCI as compared to 24 cognitively healthy elderly controls using PASL. In line with nuclear imaging methods, lower perfusion in patients with MCI and AD was found mainly in the parietal lobe, but also in angular and middle temporal areas as well as in the left middle occipital lobe and precuneus. Our data imply that PASL may be a valuable instrument for investigating perfusion changes in the transition from normal aging to dementia and indicate that it might become an alternative to nuclear imaging techniques in AD diagnostics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21786091     DOI: 10.1007/s00406-011-0226-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  52 in total

1.  Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).

Authors:  M J de Leon; A Convit; O T Wolf; C Y Tarshish; S DeSanti; H Rusinek; W Tsui; E Kandil; A J Scherer; A Roche; A Imossi; E Thorn; M Bobinski; C Caraos; P Lesbre; D Schlyer; J Poirier; B Reisberg; J Fowler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

3.  Detecting activation in fMRI data.

Authors:  K J Worsley
Journal:  Stat Methods Med Res       Date:  2003-10       Impact factor: 3.021

4.  Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.

Authors:  Cyrus A Raji; James T Becker; Nicholas D Tsopelas; Julie C Price; Chester A Mathis; Judith A Saxton; Brian J Lopresti; Jessica A Hoge; Scott K Ziolko; Steven T DeKosky; William E Klunk
Journal:  J Neurosci Methods       Date:  2008-05-16       Impact factor: 2.390

5.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

6.  Real-time echo-planar imaging by NMR.

Authors:  P Mansfield
Journal:  Br Med Bull       Date:  1984-04       Impact factor: 4.291

7.  Smoking, lipids, and atherosclerosis.

Authors:  B S Jarstfer; N M Rich; R W Hobson; T M Geer
Journal:  Mil Med       Date:  1980-08       Impact factor: 1.437

Review 8.  Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease.

Authors:  David C Alsop; Weiying Dai; Murray Grossman; John A Detre
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Is the word 'biomarker' being properly used by proteomics research in neuroscience?

Authors:  Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-14       Impact factor: 5.270

10.  Hippocampal hyperperfusion in Alzheimer's disease.

Authors:  David C Alsop; Melynda Casement; Cedric de Bazelaire; Tamara Fong; Daniel Z Press
Journal:  Neuroimage       Date:  2008-06-17       Impact factor: 6.556

View more
  49 in total

Review 1.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease.

Authors:  Liang-Hao Guo; Christine Westerteicher; Xin-Hui Wang; Martina Kratzer; Amalia Tsolakidou; Meizi Jiang; Timo Grimmer; Simon M Laws; Panagiotis Alexopoulos; Hideaki Bujo; Alexander Kurz; Robert Perneczky
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09       Impact factor: 5.270

3.  Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions.

Authors:  David A Wolk; John A Detre
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

4.  Optimization of brain perfusion image quality by cortical surface-based projection of arterial spin labeling maps in early-onset Alzheimer's disease patients.

Authors:  Sebastien Verclytte; Renaud Lopes; Christine Delmaire; Jean-Christophe Ferre; Florence Pasquier; Xavier Leclerc
Journal:  Eur Radiol       Date:  2015-03-06       Impact factor: 5.315

5.  Template-based approach for detecting motor task activation-related hyperperfusion in pulsed ASL data.

Authors:  Jan Petr; Jean-Christophe Ferré; Hélène Raoult; Elise Bannier; Jean-Yves Gauvrit; Christian Barillot
Journal:  Hum Brain Mapp       Date:  2013-02-13       Impact factor: 5.038

6.  Innovative potential treatment strategies for schizophrenia and biomarkers for Alzheimer's disease.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-06       Impact factor: 5.270

7.  Cerebrovascular Perfusion among Older Adults with and Without Cardiovascular Disease.

Authors:  Bindal Makwana; Ariana Tart-Zelvin; Xiaomeng Xu; John J Gunstad; Denise M Cote; Athena Poppas; Ronald A Cohen; Lawrence H Sweet
Journal:  J Neuroimaging       Date:  2020-07-10       Impact factor: 2.486

8.  Cerebrovascular perfusion among older adults is moderated by strength training and gender.

Authors:  Xiaomeng Xu; Beth A Jerskey; Denise M Cote; Edward G Walsh; Jason J Hassenstab; Maura E Ladino; Uraina S Clark; Donald R Labbe; John J Gunstad; Athena Poppas; Ronald A Cohen; Richard D Hoge; Lawrence H Sweet
Journal:  Neurosci Lett       Date:  2013-12-17       Impact factor: 3.046

9.  Decreased physical activity predicts cognitive dysfunction and reduced cerebral blood flow in heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Naftali Raz; Lawrence H Sweet; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Neurol Sci       Date:  2014-02-18       Impact factor: 3.181

10.  Regional Cerebral Blood Flow during Wakeful Rest in Older Subjects with Mild to Severe Obstructive Sleep Apnea.

Authors:  Andrée-Ann Baril; Katia Gagnon; Caroline Arbour; Jean-Paul Soucy; Jacques Montplaisir; Jean-François Gagnon; Nadia Gosselin
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.